Sumitomo Pharma Co., Ltd. (TYO: 4506)

Sumitomo Pharma Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	99,082	29,047	143,478	202,984	193,698	101,708
Cash & Short-Term Investments	99,082	29,047	143,478	202,984	193,698	101,708
Cash Growth	64.05%	-79.76%	-29.32%	4.79%	90.45%	-25.92%
Accounts Receivable	66,063	81,023	95,908	151,407	135,866	134,491
Other Receivables	2,823	16,216	2,722	93	194	5,877
Receivables	68,886	97,239	98,630	151,500	136,060	140,368
Inventory	105,637	115,350	94,405	99,021	92,215	79,368
Other Current Assets	38,324	27,933	45,347	46,016	37,822	42,646
Total Current Assets	311,929	269,569	381,860	499,521	459,795	364,090
Property, Plant & Equipment	57,368	57,895	58,909	64,091	64,966	65,748
Long-Term Investments	59,357	182,368	144,399	127,909	203,277	205,096
Goodwill	188,549	199,783	209,415	195,144	176,492	169,046
Other Intangible Assets	179,992	195,652	329,314	398,692	383,406	421,791
Long-Term Deferred Tax Assets	2,570	2,239	10,845	22,650	20,191	27,107
Total Assets	799,765	907,506	1,134,742	1,308,007	1,308,127	1,252,878
Accounts Payable	58,581	67,720	52,141	46,183	64,638	62,251
Short-Term Debt	255,950	174,588	90,588	5,025	5,000	270,000
Current Portion of Long-Term Debt	-	110,929	-	20,060	4,960	2,960
Current Portion of Leases	-	3,781	4,660	5,463	5,900	5,786
Current Income Taxes Payable	18,629	1,348	24,053	7,583	24,511	22,637
Other Current Liabilities	151,017	157,108	199,446	194,059	173,138	132,864
Total Current Liabilities	484,177	515,474	370,888	278,373	278,147	496,498
Long-Term Debt	133,430	133,367	244,128	243,963	263,859	25,020
Long-Term Leases	-	5,199	6,996	10,033	10,961	11,493
Long-Term Deferred Tax Liabilities	14,124	38,211	36,505	26,550	28,424	26,867
Other Long-Term Liabilities	42,740	47,969	64,435	64,058	63,489	37,025
Total Liabilities	685,521	751,370	727,960	634,438	659,949	620,773
Common Stock	22,400	22,400	22,400	22,400	22,400	22,400
Additional Paid-In Capital	-	-	-	16,725	15,855	14,655
Retained Earnings	-13,254	-22,665	280,999	514,210	508,677	457,330
Treasury Stock	-682	-682	-682	-681	-679	-677
Comprehensive Income & Other	105,706	157,010	104,032	55,234	34,317	35,777
Total Common Equity	114,170	156,063	406,749	607,888	580,570	529,485
Minority Interest	74	73	33	65,681	67,608	102,620
Shareholders' Equity	114,244	156,136	406,782	673,569	648,178	632,105
Total Liabilities & Equity	799,765	907,506	1,134,742	1,308,007	1,308,127	1,252,878
Total Debt	389,380	427,864	346,372	284,544	290,680	315,259
Net Cash (Debt)	-290,298	-398,817	-202,894	-81,560	-96,982	-213,551
Net Cash Per Share	-730.69	-1003.84	-510.69	-205.29	-244.11	-537.51
Filing Date Shares Outstanding	397.29	397.29	397.29	397.29	397.29	397.29
Total Common Shares Outstanding	397.29	397.29	397.29	397.29	397.29	397.3
Working Capital	-172,248	-245,905	10,972	221,148	181,648	-132,408
Book Value Per Share	287.37	392.82	1023.80	1530.08	1461.31	1332.72
Tangible Book Value	-254,371	-239,372	-131,980	14,052	20,672	-61,352
Tangible Book Value Per Share	-640.26	-602.51	-332.20	35.37	52.03	-154.42

Source: S&P Capital IQ. Standard template. Financial Sources.